SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ONXX
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
810 61 0 ONXX
Emcee:  (no name provided) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
810Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survivtnsaf-7/22/2009
809Onyx acquires option to license 2 JAK2 inhibitors from S*BIO, one in Phase I foridos-1/7/2009
808<i>Tuck, the shot may have gone into a different goal. Jason</i> Netnsaf-5/20/2008
807>How much more unexpected bad news can there be?< Not too many in the neaidos-2/20/2008
806First shot on lung cancer goal goes wide: >>Bayer and Onyx Provide Updatetuck-2/19/2008
805ML (the price action sure ain't neutral): Ex-US sales drive growth, liver dtom pope-2/17/2007
804Nexavar in lung cancer: onctalk.com Cheers, Tucktuck-12/29/2006
803Onyx Plunges on Nexavar Results By TSC Staff 6/5/2006 11:52 AM EDT URL: thestreDoc Bones-6/6/2006
802[BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cellstuck-2/7/2006
801<i>Old news?</i> It’s old news that VEGF inhibition raises BP. (E.gDewDiligence_on_SI-2/1/2006
800[Mechanisms of Hypertension Associated With BAY 43-9006] >>JCO Early Reletuck-2/1/2006
799Mayo Clinic finds kidney cancer patients are unlikely to respond to potential trJohn McCarthy-12/21/2005
798PHOTO ADVISORY -- FDA Approves Nexavar(R) for Treatment of Patients with AdvanceJohn McCarthy-12/21/2005
797<i>>I would guess the p value for the final result to be called a succeDewDiligence_on_SI-11/8/2005
796If the survival trend holds up, that number could be better than Sutent's. tuck-11/8/2005
795Interim survival data reported at ECCO: investorshub.comDewDiligence_on_SI-11/3/2005
794Should I hold, or sell before the stock goes even lower than it has post ASCO???PSC-7/26/2005
793[RCC NDA filed] >>WEST HAVEN, Conn. and EMERYVILLE, Calif., July 11 /PRNetuck-7/11/2005
792>>WEST HAVEN, Conn. and EMERYVILLE, Calif., April 18 /PRNewswire-FirstCalltuck-4/18/2005
791BAY 43-9006 Shown to Delay Disease Progression in Phase III Study in Advanced Kinigel bates-3/21/2005
790Did very well, thanks. (eom)scaram(o)uche-11/16/2004
789<<I don't understand any focus on formal responses. IMO ttp is the ratMiljenko Zuanic-10/28/2004
788Ah, I see what you're saying. Thanks. Wish you'd have been on the confscaram(o)uche-10/28/2004
787<<I'm impressed that the discontinuation arms diverged to the level ofMiljenko Zuanic-10/27/2004
786I'm impressed that the discontinuation arms diverged to the level of "sscaram(o)uche-10/27/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News